Naar de inhoud
Global sound
The CheckRare Brief

The CheckRare Brief

First-Line Therapy Approved for Rare Lung Cancer

· 8 min · Seizoen 1 Aflevering 7

Beschrijving

This week, three developments highlight the rapidly changing rare disease treatment landscape: a Phase 3 setback in Angelman syndrome, continued competition in hereditary angioedema, and an FDA decision expanding access to a targeted lung cancer therapy.

Angelman Syndrome: Phase 3 Trial Misses Its Marks
Ultragenyx announced results from its Phase 3 Aspire study of apazunersen in Angelman syndrome. The trial did not meet its primary or key secondary endpoints.

Angelman syndrome is a rare neurodevelopmental disorder caused by the loss of a working copy of the UBE3A gene. Patients generally…

Website: spreaker.com

Live, afgelopen uur: 7.155 nummers op 2.991 zenders in 110 landen

Ontdek de wereld via de radio

Meer manieren om te ontdekken (7)

Iets moois gehoord? Bewaar het, of open het direct in Spotify.

★ Artiest van de week De snelste stijger op de radio deze week
Jouw nummer hier? Vanaf € 9 per week →
Nostalgie Les Plus Grands Tubes FrançaisVerder luisteren